{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:46Z","timestamp":1787009986246,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/grf.0b013e31828e92c0","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T06:07:47Z","timestamp":1365142067000},"page":"372-381","source":"Crossref","is-referenced-by-count":61,"title":["Myasthenia Gravis and Pregnancy"],"prefix":"10.1097","volume":"56","author":[{"given":"MICHAEL","family":"VARNER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210126","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000329491","article-title":"Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis.","volume":"18","author":"Mays","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"R2-19-20210126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1196\/annals.1254.053","article-title":"The epidemiology of myasthenia gravis.","volume":"998","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"R3-19-20210126","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis.","volume":"330","author":"Drachman","year":"1994","journal-title":"N Engl J Med"},{"key":"R5-19-20210126","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0733-8619(18)30099-9","article-title":"The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome.","volume":"12","author":"Howard","year":"1994","journal-title":"Neurol Clin"},{"key":"R6-19-20210126","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":". Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"R7-19-20210126","first-page":"5","article-title":"The emerging diversity of neuromuscular junction disorders.","volume":"XXVI","author":"Newsom-Davis","year":"2007","journal-title":"Acta Myologica"},{"key":"R8-19-20210126","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2004-829589","article-title":". Seronegative myasthenia gravis.","volume":"24","author":"Vincent","year":"2004","journal-title":"Sem Neurol"},{"key":"R9-19-20210126","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":". Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"R10-19-20210126","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":". Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol"},{"key":"R11-19-20210126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3988\/jcn.2012.8.3.161","article-title":". Incidence of thymoma in myasthenia gravis: a systematic review.","volume":"8","author":"Mao","year":"2012","journal-title":"J Clin Neurol"},{"key":"R12-19-20210126","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.1017","article-title":". Mature, long-lived CD4 and CD8 T cells are generated by the thymoma in myasthenia gravis.","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann Neurol"},{"key":"R14-19-20210126","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejrad.2007.10.002","article-title":". Anterior mediastinal tumors: diagnostic accuracy of CT and MRI.","volume":"69","author":"Tomiyama","year":"2009","journal-title":"Eur J Radiol"},{"key":"R15-19-20210126","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ejcts.2007.01.024","article-title":". Role of fluorine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.","volume":"31","author":"El-Bawab","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"R16-19-20210126","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.35.8.1219","article-title":"Myasthenic crisis after intervenous administration of iodinated contrast agent.","volume":"35","author":"Chagnac","year":"1985","journal-title":"Neurology"},{"key":"R17-19-20210126","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00006250-198309000-00013","article-title":"Myasthenia gravis and pregnancy. A reappraisal of thymectomy.","volume":"62","author":"Eden","year":"1983","journal-title":"Obstet Gynecol"},{"key":"R18-19-20210126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1331.2006.01538.x","article-title":"Myasthenia gravis in pregnancy and birth: identifying risk factors, optimizing care.","volume":"14","author":"Hoff","year":"2007","journal-title":"Eur J Neurol"},{"key":"R19-19-20210126","first-page":"330","article-title":"C, deSeze J, Delrieu O, et al.. Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase.","volume":"162","year":"2006","journal-title":"Rev Neurol"},{"key":"R20-19-20210126","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coph.2004.12.007","article-title":"Current understanding of congenital myasthenic syndromes.","volume":"5","author":"Engel","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"R21-19-20210126","first-page":"12","article-title":"Congenital myasthenic syndromes.","volume":"4","author":"Beeson","year":"2005","journal-title":"Adv Clin Neurosci Rehabil"},{"key":"R22-19-20210126","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00019052-200410000-00004","article-title":". Congenital myasthenic syndromes.","volume":"17","author":"Hantai","year":"2004","journal-title":"Cur Opin Neurol"},{"key":"R23-19-20210126","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1212\/WNL.52.3.447","article-title":". Course and treatment of myasthenia gravis during pregnancy.","volume":"52","author":"Batocchi","year":"1999","journal-title":"Neurology"},{"key":"R24-19-20210126","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00003081-198309000-00010","article-title":"Myasthenia gravis.","volume":"26","author":"Plauche","year":"1983","journal-title":"Clin Obstet Gynecol"},{"key":"R25-19-20210126","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejogrb.2005.01.002","article-title":". Myasthenia gravis: management issues during pregnancy.","volume":"12","author":"Ferrero","year":"2005","journal-title":"Eur J Obstet Gynecol"},{"key":"R26-19-20210126","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1073\/pnas.77.6.3635","article-title":"Inhibitory effect of alpha fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.","volume":"77","author":"Brenner","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-19-20210126","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/01.WNL.0000082725.21444.EC","article-title":"Myasthenia gravis: consequences for pregnancy, delivery, and the newborn.","volume":"61","author":"Hoff","year":"2003","journal-title":"Neurology"},{"key":"R28-19-20210126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/NDT.S8915","article-title":". Current and emerging therapies for the treatment of myasthenia gravis.","volume":"7","author":"Mantegazza","year":"2011","journal-title":"Neuropsych Dis Treat"},{"key":"R29-19-20210126","first-page":"568","article-title":"Long-term corticosteroid treatment of myasthenia gravis.","volume":"505","author":"Johns","year":"1987","journal-title":""},{"key":"R31-19-20210126","first-page":"1346","article-title":"Myasthenia gravis during pregnancy.","volume":"58","author":"Chaudhry","year":"2012","journal-title":"Can Fam Physician"},{"key":"R32-19-20210126","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/bdra.20399","article-title":"Pregnancy outcome of women exposed to azathioprine during pregnancy.","volume":"79","author":"Goldstein","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R33-19-20210126","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.crohns.2010.10.005","article-title":". Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding.","volume":"5","author":"Angelberger","year":"2011","journal-title":"J Crohns Colitis"},{"key":"R34-19-20210126","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJMra020526","article-title":"Pharmacogenomicsdrug disposition, drug targets, and side effects.","volume":"348","author":"Evans","year":"2003","journal-title":"N Engl J Med"},{"key":"R35-19-20210126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/11316280-000000000-00000","article-title":". Long-term neurodevelopment of children exposed in utero to cyclosporine after maternal renal transplant.","volume":"12","author":"Nulman","year":"2010","journal-title":"Pediatric Drugs"},{"key":"R36-19-20210126","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":". Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis.","volume":"316","author":"Tindall","year":"1098","journal-title":"N Engl J Med"},{"key":"R38-19-20210126","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/archneur.62.11.1689","article-title":". Myasthenia gravis clinical study group. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin; a randomized double-blind clinical trial.","volume":"62","author":"Gajdos","year":"2005","journal-title":"Arch Neurol"},{"key":"R39-19-20210126","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":". Evidence-based guideline update: plasmapheresis in neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"key":"R40-19-20210126","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00207454.2010.539307","article-title":". Frequency of autoimmune diseases in myasthenia gravis: a systematic review.","volume":"121","author":"Mao","year":"2011","journal-title":"Int J Neurosci"},{"key":"R41-19-20210126","first-page":"35S","article-title":"Myasthenia gravis and preeclampsia.","volume":"48","author":"Cohen","year":"1976","journal-title":"Obstet Gynecol"},{"key":"R42-19-20210126","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.grf.0000153206.85996.07","article-title":"Myasthenia gravis and pregnancy.","volume":"48","author":"Stafford","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"R43-19-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pd.1970110104","article-title":". Prenatal diagnosis of congenital myasthenia with arthrogryposis in a myasthenic mother.","volume":"11","author":"Stoll","year":"1991","journal-title":"Prenatal Diagnosis"},{"key":"R44-19-20210126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hcn152","article-title":"Myasthenic crisis.","volume":"102","author":"Chaudhuri","year":"2009","journal-title":"QJM"},{"key":"R45-19-20210126","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00415-012-6709-x","article-title":". Pregnancy in congenital myasthenic syndrome.","volume":"260","author":"Servais","year":"2013","journal-title":"J Neurol"},{"key":"R46-19-20210126","first-page":"222","article-title":"Antiacetylcholine receptor antibody in neonatal myasthenia gravis.","volume":"135","author":"Donaldson","year":"1981","journal-title":"Am J Dis Child"},{"key":"R47-19-20210126","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1212\/WNL.33.2.133","article-title":"Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children.","volume":"33","author":"Lefvert","year":"1983","journal-title":"Neurology"},{"key":"R48-19-20210126","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1172\/JCI119048","article-title":". Association of arthrogryposis multiplex congenital with maternal antibodies inhibiting fetal acetylcholine receptor function.","volume":"98","author":"Riemersma","year":"1996","journal-title":"J Clin Invest"},{"key":"R50-19-20210126","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/mus.20734","article-title":"Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.","volume":"35","author":"Stickler","year":"2007","journal-title":"Muscle Nerve"}],"container-title":["Clinical Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0b013e31828e92c0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:36:27Z","timestamp":1620938187000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201306000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0b013e31828e92c0","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}